Skip to Content

Hartford International Opp HLS IB HBIOX

Medalist Rating as of | See Hartford Funds Investment Hub
  • NAV / 1-Day Return 15.73  /  +1.35 %
  • Total Assets 855.6 Mil
  • Adj. Expense Ratio
    1.000%
  • Expense Ratio 1.000%
  • Distribution Fee Level High
  • Share Class Type Institutional
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment
  • Status Open
  • TTM Yield 0.86%
  • Turnover 91%

USD | NAV as of Feb 22, 2024 | 1-Day Return as of Feb 22, 2024, 11:13 PM GMT+0

Morningstar’s Analysis HBIOX

Will HBIOX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Hartford International Opp HLS IB's Average People Pillar and Process Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HBIOX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 25.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Taiwan Semiconductor Manufacturing Co Ltd

3.33 29.1 Mil
Technology

Samsung Electronics Co Ltd

3.12 27.3 Mil
Technology

Novartis AG Registered Shares

2.70 23.6 Mil
Healthcare

Sony Group Corp

2.38 20.8 Mil
Technology

AstraZeneca PLC

2.35 20.5 Mil
Healthcare

ASML Holding NV

2.32 20.3 Mil
Technology

Shell PLC

2.26 19.8 Mil
Energy

Tencent Holdings Ltd

2.25 19.6 Mil
Communication Services

Rio Tinto PLC Registered Shares

2.22 19.4 Mil
Basic Materials

Siemens AG

2.14 18.7 Mil
Industrials